Experts from academia, industry and government are invited to present timely research in all areas of tissue engineering and regenerative medicine including:
- Scaffolds, Matrices and Biomaterials
- Stem Cells and Cell Therapies and Development Biology and Cell Signaling
- Engineering Tissues for In Vitro Screening and Diagnostics Imaging
- Biofabrication and Bioreactors
- Drug Delivery
- Paracrine/Trophic Delivery
- Immunology/Immunoengineering in Tissue Engineering
- Tumor Development and Cancer
- Physical Parameters in Tissue Development
- Computations Modeling, Systems Biology, and Multi-parametric Analysis
- Preclinical Animal Models
- Tissue-Organ Functional Replacement
- Neural and Spine
- Dental and Craniofacial
- Respiratory, Urologic and Gastrointestinal
- Skin and Wound Healing and Inflammation
Composite Tissue-Organ Transplantation and Tissue Engineering
- Imaging and Assessment
- Quality of scientific content
- Originality of research
- Contribution and relevance to the field of tissue engineering/regenerative medicine
- Adherence to abstract template format
- Abstracts that are not supported by full technical disclosure or are largely promotional rather than scientific in nature are discouraged.
The abstract should clearly describe the nature of the research and the problem it addresses, and be presented in such language as to be understood by scientists representing the multi-disciplinary nature of tissue engineering. The abstract should summarize the objectives of the research, the methodology employed, results, and their significance.
- The abstract length is limited to 250 words.
- Please no figures or tables in the abstract.
- All abstracts will be published in the "Tissue Engineering, Part A" journal, if do not wish to have your abstract published please indicate so during your submission. All authors will have to agree to the submission and the publication of the abstract.
Title: Title should be brief, clearly indicating the nature of the presentation. Title should be in bold font and mixed case font followed by a single return. Do not put a period at the end of the title.
Example for Title: This is a Properly Formatted Abstract Title
Author(s): In upper and lower case letters as follows: First Name, Middle Initial Last Name of each author (underline the name of the presenting author) with the corresponding institution of the author's. Follow with a single return.
** Presenting authors are expected to pay their own travel expenses and conference registration fee(s).
Complete contact information (name, mailing address, and e-mail) for each author listed on the abstract must be entered before submitting the abstract file.
References: May be included at the end. Please use a standard format, such as that shown below:
1. Langer R, Vacanti JP. Tissue Engineering. Science 260, 920, 1993.
Acknowledgments: Support from outside sources, such as Research Grants, should be listed here. Based on the standards set by the Accreditation Council for Continuing Medical Education and guidelines of the Food and Drug Administration as endorsed by the American Medical Association, any conflict of interest must be clearly recognizable. The indication of outside support does not affect the decision of abstract acceptance or rejection.
Disclosures: Include any disclosure information here. In order for your colleagues to properly evaluate the information, analysis and opinions presented in your abstract, it is important that they be informed of potential conflicts of interest pertinent to the research submitted. Therefore, conference management requires that all authors provide any relevant information concerning personal or professional circumstances and relationships that might reasonably be expected to affect the author's view on the subject. Examples include, but are not limited to:
- Stock options or bond holdings in a for-profit corporation or self-directed pension plan
- Employment (full or part-time)
- Ownership or partnership
- Consulting fees or other remuneration (payment)
- Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
- Receipt of royalties
- Speakers bureau
Appropriate disclosure will be stated in the scientific program and the abstract volume. If you do not have anything to disclose, you must indicate this on the online abstract submission form. The disclosure information you provide will not influence the review of your abstract. Abstracts will not be reviewed without proper completion of the disclosure section on the abstract submission form. Disclosure information for all authors is required upon abstract submission.